Cardiac outcomes in adults with supravalvar aortic stenosis by Greutmann, Matthias et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2012
Cardiac outcomes in adults with supravalvar aortic stenosis
Greutmann, Matthias; Tobler, Daniel; Sharma, Nakul Chander; Vonder Muhll, Isabelle; Mebus,
Siegrun; Kaemmerer, Harald; Schuler, Pia K; Deanfield, John E; Beauchesne, Luc; Salehian, Omid;
Hoffmann, Andreas; Golovatyuk, Vasilisa; Oechslin, Erwin N; Silversides, Candice K
Abstract: AIMS: Supravalvar aortic stenosis is a rare form of left ventricular outflow tract obstruction
that is often progressive in childhood. Little data are available on outcomes in the adult population.
Our aim was to define cardiac outcomes in adults with supravalvar aortic stenosis. METHODS AND
RESULTS: This is a multicentre retrospective study of cardiac outcomes in adults (￿18 years) with
supravalvar aortic stenosis. We examined: (i) adverse cardiac events (cardiovascular death, myocardial
infarction, stroke, heart failure, sustained arrhythmias, and infective endocarditis) and (ii) the need for
cardiac surgery in adulthood. One hundred and thirteen adults (median age at first visit 19 years; 55%
with Williams-Beuren syndrome; 67% with surgical repair in childhood) were identified. Adults without
Williams-Beuren syndrome had more severe supravalvar aortic stenosis and more often associated left
ventricular outflow tract obstructions (P < 0.001). In contrast, mitral valve regurgitation was more
common in patients with Williams-Beuren syndrome. Eighty-five per cent of adults (96/113) had serial
follow-up information (median follow-up 6.0 years). Of these patients, 13% (12/96) had an adverse cardiac
event and 13% (12/96) had cardiac operations (7 valve repair or replacements, 4 supravalvar aortic stenosis
repairs, 1 other). Cardiac surgery was more common in adults without Williams-Beuren syndrome (P =
0.007). Progression of supravalvar aortic stenosis during adulthood was rare. CONCLUSION: Adults with
supravalvar aortic stenosis remain at risk for cardiac complications and reoperations, while progression of
supravalvar aortic stenosis in adulthood is rare. Valve surgery is the most common indication for cardiac
surgery in adulthood.
DOI: 10.1093/eurheartj/ehs206
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: http://doi.org/10.5167/uzh-75976
Accepted Version
Originally published at:
Greutmann, Matthias; Tobler, Daniel; Sharma, Nakul Chander; Vonder Muhll, Isabelle; Mebus, Siegrun;
Kaemmerer, Harald; Schuler, Pia K; Deanfield, John E; Beauchesne, Luc; Salehian, Omid; Hoffmann,
Andreas; Golovatyuk, Vasilisa; Oechslin, Erwin N; Silversides, Candice K (2012). Cardiac outcomes in
adults with supravalvar aortic stenosis. European Heart Journal, 33(19):2442-2450. DOI: 10.1093/eur-
heartj/ehs206
 1/22 
 
Cardiac outcomes in adults with supravalvar aortic stenosis 
 
 
 
Matthias Greutmann, MD *† , Daniel Tobler, MD *‡, Nakul Chander Sharma, MD §, Isabelle 
VonderMuhll, MD §, Siegrun Mebus, MD ║, Harald Kaemmerer, MD ║, Pia Schuler, MD ¶, 
John E. Deanfield, MD ¶, Luc Beauchesne, MD #, Omid Salehian, MD **, Andreas Hoffmann, 
MD ‡, Vasilisa Golovatyuk †, Erwin N. Oechslin, MD ‡‡, Candice K. Silversides, MD ‡‡ 
 
*these authors contributed equally to the study design, data interpretation and manuscript 
preparation 
 
Affiliations: 
† Adult Congenital Heart Disease Program, University Hospital, Zurich, Switzerland  
‡ Adult Congenital Heart Disease Clinic, University Hospital, Basel, Switzerland  
§ Northern Alberta Adult Congenital Heart Clinic, University of Alberta Hospital, Edmonton, 
Canada  
║ German Heart Centre Munich, Technical University Munich, Congenital Heart Disease Clinic, 
Munich, Germany 
¶ Grown Up Congenital Heart Disease Unit, The Heart Hospital, London, United Kingdom 
# Ottawa Heart Institute Adult Congenital Heart Disease Clinic, University of Ottawa, Canada  
** McMaster University Adult Congenital Cardiac Clinic, McMaster University, Hamilton, 
Canada 
‡‡ Toronto Congenital Cardiac Center for Adults, Peter Munk Cardiac Centre/Toronto General 
Hospital, and University of Toronto, Canada 
 
 
Conflicts of interest: None 
Relationship to industry: None 
 
 
Address for correspondence 
Matthias Greutmann, MD, University hospital of Zurich, Raemistrasse 100, 8091 Zurich, 
Switzerland. Tel.: ++41 44 255 3883, Fax: ++41 44 255 8701, Email: 
Matthias.Greutmann@usz.ch 
 
 
Word counts: Abstract: 244 words, entire manuscript: 5243 words 
 
 
 2/22 
Abstract 
Aims: Supravalvar aortic stenosis is a rare form of left ventricular outflow tract obstruction that is 
often progressive in childhood. Little data is available on outcomes in the adult population. Our 
aim was to define cardiac outcomes in adults with supravalvar aortic stenosis. 
Methods and Results: This is a multicenter retrospective study of cardiac outcomes in adults 
(≥18 years) with supravalvar aortic stenosis. We examined:  a) adverse cardiac events 
(cardiovascular death, myocardial infarction, stroke, heart failure, sustained arrhythmias and 
infective endocarditis) and b) the need for cardiac surgery in adulthood. One hundred and thirteen 
adults [median age at first visit 19 years; 55% with Williams-Beuren syndrome; 67% with 
surgical repair in childhood] were identified. Adults without Williams-Beuren Syndrome had 
more severe supravalvar aortic stenosis and more often associated left ventricular outflow tract 
obstructions (p<0.001). In contrast, mitral valve regurgitation was more common in patients with 
Williams-Beuren syndrome. Eighty-five percent of adults (96/113) had serial follow-up 
information (median follow-up 6.0 years). Of these patients, 13% (12/96) had an adverse cardiac 
event and 13% (12/96) had cardiac operations (7 valve repair or replacements, 4 supravalvar 
aortic stenosis repairs, 1 other). Cardiac surgery was more common in adults without Williams-
Beuren syndrome (p=0.007). Progression of supravalvar aortic stenosis during adulthood was 
rare. 
Conclusion: Adults with supravalvar aortic stenosis remain at risk for cardiac complications and 
reoperations, while progression of supravalvar aortic stenosis in adulthood is rare. Valve surgery 
is the most common indication for cardiac surgery in adulthood. 
 
Key words: Congenital heart disease, Supravalvar aortic stenosis, Williams Beuren syndrome
 3/22 
Supravalvar aortic stenosis is a rare form of left ventricular outflow tract obstruction.  While it 
may be associated with the Williams-Beuren syndrome, 
1
 it can also occur as familial disease 
without features of Williams-Beuren syndrome, in conjunction with other forms of obstructive 
left ventricular outflow tract lesions or as an isolated lesion. The supravalvar lesion may involve 
the entire aortic root, the coronary arteries and/or the aortic valve 
2, 3
 and in children it is felt to be 
a progressive disease, 
4-6
 perhaps related to an inadequate growth of the supravalvar aortic root 
and the sinotubular junction. 
4
 Children with supravalvar aortic stenosis often have early 
intervention as the supravalvar stenosis is known to be progressive. 
7-11
 The clinical course 
beyond childhood, in the operated and unoperated adult, is not well studied. 
8, 11, 12
 Therefore, the 
aim of this study was to examine late cardiovascular events in adults with supravalvar aortic 
stenosis and to identify features associated with increased risk for late cardiovascular 
complications. The secondary objective was to investigate progression of the supravalvar 
obstruction during adulthood.  
 
 
Methods 
Study Design and Study Cohort 
This was a multicenter retrospective study of unoperated and repaired adults ( 18 years 
of age) with a diagnosis of supravalvar aortic stenosis. Adults with an outpatient visit at one of 
the participating tertiary adult congenital cardiac clinics were included. The following centers 
participated in the study: Toronto Congenital Cardiac Center for Adults, University Health 
Network, University of Toronto, Toronto, Canada; Northern Alberta Adult Congenital Heart 
Clinic, University of Alberta Hospital, Edmonton, Canada; McMaster University Adult 
Congenital Cardiac Clinic, McMaster University, Hamilton, Canada; Ottawa Heart Institute Adult 
Congenital Heart Disease Clinic, University of Ottawa, Canada; German Heart Centre Munich, 
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Technical University Munich, Congenital Heart Disease Clinic, Munich, Germany; Grown Up 
Congenital Heart Disease Unit, The Heart Hospital, London, United Kingdom; Adult Congenital 
Heart Disease Clinic, University Hospital, Basel, Switzerland and Adult Congenital Heart 
Disease Program, University Hospital, Zurich, Switzerland. The study was approved by the 
institutional ethics boards. 
The diagnosis of supravalvar aortic stenosis was documented by cardiac catheterization, 
echocardiography, or magnetic resonance imaging. Supravalvar aortic stenosis was classified as 
localized when it was limited to the sinotubular junction and the proximal ascending aorta. It was 
classified as diffuse when the narrowing was less circumscript and also involved the ascending 
aorta beyond the proximal portion extending to the aortic arch or the descending aorta. 
Classification was left to the discretion of the treating physician. Patients were excluded if an 
echocardiogram was not available as part of their initial assessment.  
Outcomes of Interest 
When available, serial clinical and echocardiographic data after the initial presentation to 
the adult clinic was collected. The primary outcomes of interest were: a) adverse cardiovascular 
events in adulthood and b) the need for cardiac surgery in adulthood. Adverse cardiovascular 
events were defined as cardiovascular death (specified as sudden or not sudden), sustained (>30 
seconds) supraventricular or ventricular arrhythmias, acute coronary syndromes, cerebrovascular 
events, new onset heart failure or infective endocarditis. Secondary outcomes included: a) 
postoperative complications related to prior surgery of supravalvar stenosis including aneurysms 
or pseudoaneurysms at the site of previous patch repair, b) echocardiographic evidence of 
recurrent stenosis at the supravalvar level and c) progression of supravalvar aortic stenosis in 
adulthood.  
Data Collection  
Baseline clinical, electrocardiographic and echocardiographic data were obtained by chart 
review. Baseline clinical variables at the first clinic visit included: age at first visit, gender, 
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diagnosis of Williams-Beuren syndrome, details pertaining to other congenital cardiac lesions 
specifically those associated with left ventricular outflow tract obstruction, type of supravalvar 
aortic stenosis at diagnosis, history of systemic arterial hypertension, New York Heart 
Association functional class, medical therapy and surgical and non-surgical interventions in 
childhood. Electrocardiographic characteristics included type of rhythm, presence of bundle 
branch block and QRS-duration.  
Echocardiographic variables included the supravalvar aortic gradients, presence and 
severity of other left ventricular outflow tract lesions, nature and severity of concomitant valvular 
lesions, right ventricular outflow tract obstruction and left ventricular systolic function. Residual 
supravalvar aortic stenosis was defined as a peak systolic velocity > 2 meters/second (peak 
systolic gradient of > 16 mmHg) at the sinotubular junction of the ascending aorta. Significant 
mitral valve disease was defined as moderate or severe regurgitation and/or stenosis (mean 
diastolic gradient of more than 5 mmHg). Significant aortic valve disease was defined as 
moderate or severe aortic regurgitation and/or stenosis (peak systolic velocity > 3m/s).
13
 To 
examine echocardiographic progression of the supravalvar stenosis, we examined the supravalvar 
gradient at three time points (when available); the last visit in childhood, the first visit in 
adulthood and the last visit in adulthood. Progression of supravalvar stenosis was defined as an 
increase in the peak systolic pressure gradient at the sinotubular junction of the ascending aorta of 
> 10 mmHg during the serial echocardiograms.  
Statistical Analysis 
The statistical analysis was performed using SPSS Version 18 (SPSS Inc., Chicago, IL).  
Continuous variables are reported as either mean +/- SD or median or interquartile range (IQR) 
(25
th
 and 75
th
 percentiles) as appropriate. Kaplan-Meier plots were used to depict survival free 
from adverse cardiovascular events and cardiac surgery in adulthood and stratified according to 
the absence or presence of Williams-Beuren syndrome.  A Cox proportional hazard model was 
used to identify determinants of adverse cardiac outcomes and the need for cardiac surgery in 
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adulthood. Significance of changes in peak supravalvar systolic gradients between the first clinic 
visit in adulthood and the last clinic visit were determined using the Wilcoxon Signed Rank test. 
A p-value <0.05 (two-sided) was considered to be significant. 
 
 
Results 
Baseline Characteristics  
A total of 113 patients with supravalvar aortic stenosis were identified. Sixty-two patients 
(55%) with supravalvar aortic stenosis had the Williams-Beuren syndrome.  Other baseline 
characteristics are presented in Table 1A and 1B. Patients without Williams-Beuren syndrome 
more commonly had other left-sided outflow tract obstructive lesions (22/51 (43%) versus 2/62 
(3%), p < 0.0001) including aortic valve stenosis (14 patients), subvalvar aortic stenosis (6 
patients) and coarctation of the aorta (12 patients). Only 2 patients (2%), both without Williams-
Beuren syndrome, had a parachute mitral valve (Shone’s complex, defined as the presence of 
multiple levels of left ventricular outflow tract obstruction and left ventricular inflow 
obstruction). Seventy-six patients (67%) had undergone surgical repair of supravalvar aortic 
stenosis in childhood. The median age at operation was 7.1 years (IQR 1.4-11.2). Of those 37 
patients who had no operation for supravalvar aortic stenosis in childhood, 32 (87%) had 
Williams-Beuren-Syndrome. Those who underwent surgical repair of supravalvar aortic stenosis 
in childhood were more likely to have other left ventricular outflow tract obstructions (29% 
versus 5%, p = 0.004), were more likely to have moderate or severe aortic valve regurgitation at 
first visit in adulthood (15% versus 0%, p = 0.015) and were less likely to have residual 
supravalvar aortic stenosis at first visit in adulthood (36% versus 65%, p = 0.003). Right bundle 
branch block at first visit in adulthood was more common in patients with surgery for supravalvar 
aortic stenosis in childhood (15% vs. 3%, p = 0.057). 
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Adults with Williams-Beuren syndrome were less likely to have additional left 
ventricular outflow tract obstruction. Those without the diagnosis of Williams-Beuren syndrome 
appeared to have more severe forms of supravalvar aortic stenosis and more complex left-sided 
outflow tract disease. In childhood, they more commonly had undergone surgical repair of 
supravalvar aortic stenosis (90% versus 48%, p < 0.001) and more often had undergone multiple 
surgical procedures (57% versus 15%, p<0.0001). At first assessment in the adult clinic, they 
were more likely to have significant supravalvar aortic stenosis (41% versus 5%, p < 0.001), 
more likely to have aortic valve stenosis or regurgitation (33% versus 3%, p < 0.0001) and more 
commonly had a complete right bundle branch block on their electrocardiogram (18% versus 5%, 
p = 0.028). Presentation with a right bundle branch block on the electrocardiogram was more 
common in patients who had multiple cardiac operations in childhood (26% versus 3%, p < 
0.0001).  
In contrast, mitral valve regurgitation was more common in adults with Williams-Beuren 
syndrome. Moderate or severe mitral valve regurgitation at first assessment in the adult clinic was 
present in 4 patients (4%); all of whom had Williams-Beuren syndrome. Significant mitral 
stenosis at first presentation in the adult clinic was present in 3 patients. One of the adults with 
significant mitral stenosis had Williams-Beuren syndrome and mitral valve repair at age 17. The 
other two patients were non-syndromic and had dysplastic mitral valves. Three patients had mild 
right ventricular outflow tract obstruction (peak gradients of 33 mmHg, 35 mmHg and 40 mmHg, 
respectively).  
Adverse Cardiovascular Events in Adults 
Serial clinical follow-up information was available in 85% (96/113) of patients. Of those 
17 patients who had only one clinic visit in adulthood, all had been seen for the first time in the 
adult clinic within the last 3 years and were scheduled for regular follow-up visits in the future. 
Sixteen patients had just transitioned from pediatric care and were less than 20 years old at first 
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visit in adulthood. Baseline characteristics of patients with clinical follow-up did not differ from 
patients without follow up.  
The median follow-up duration was 6.0 years (IQR 2.1-11.4, range 0.1-30.0) after the 
initial clinic presentation. The median age at last follow up was 27.3 years (range 18.2-57.9). For 
those patients who had surgical resection of supravalvar aortic stenosis in childhood, the mean 
follow-up interval after surgery was 20.7 ± 8.4 years (maximum 42 years). 
During the follow-up period, 12 patients (13%) experienced a total of 20 cardiovascular 
complications (Table 2). The 2 deaths were associated with heart failure in the setting of severe 
mitral regurgitation. Kaplan-Meier survival curves for late adverse cardiovascular events and 
reoperation are shown in Figure 1.  
At first clinic visit in adulthood, patients with cardiovascular complications had higher 
left ventricular mass (124 ± 27 g/m
2
 versus 90 ± 31 g/m
2
, p = 0.003) and lower left ventricular 
fractional shortening (30 ± 8% versus 40 ± 8%, p = 0.001) compared to those without 
complications, while left ventricular ejection fraction was not significantly different (61 ± 4% 
versus 63 ± 7%, p = 0.42).  
 For patients with new onset heart failure during follow-up compared to those without, 
baseline left ventricular ejection fraction was not different (59 ± 3% versus 63 ± 7%, p = 0.20). 
Of the 7 patients who developed clinical heart failure, 3 had moderate to severe mitral 
regurgitation, 1 had severe tricuspid regurgitation, 1 had severe aortic regurgitation and 1 had 
severe supravalvar aortic stenosis. Three patients had an abnormal left ventricular ejection 
fraction, including one patient requiring support by a left ventricular assist device. In all patients 
with abnormal left ventricular ejection fraction, the coronary arteries were documented to be 
normal by angiography. Determinants of adverse cardiovascular events in adulthood are shown in 
Table 3.  
Patients without Williams-Beuren syndrome who experienced an adverse cardiovascular 
event more often had additional levels of left ventricular outflow tract obstructions compared to 
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those without an event but this did not reach statistical significance (20% versus 0%, p = 0.083). 
The rate of reoperations was not different in patients without Williams-Beuren syndrome with or 
without additional levels of left ventricular outflow tract obstruction (20% versus 19%, p = 1.0). 
Surgical repair of supravalvar aortic stenosis in childhood was not associated with cardiovascular 
complications during follow-up in adulthood (HR 5.5, 95%CI 0.7-42.9, p = 0.10). 
During follow-up 6 patients (6%) newly developed echocardiographic evidence of 
moderate or severe mitral regurgitation; 4/6 (67%) fulfilled diagnostic criteria for mitral valve 
prolapse. All of the patients with progressive mitral regurgitation had Williams-Beuren 
syndrome. This accounts for 12% of all patients with Williams-Beuren syndrome for which 
follow-up data was available. Two of these patients developed atrial fibrillation and one patient 
later died from heart failure.  
Cardiac Surgery in Adults 
Twelve patients (13%) underwent cardiac surgery during the follow-up period (Table 2). 
Of the 12 reoperations, 6 (50%) were related to aortic valve disease, including one patient with 
percutaneous pulmonary valve replacement after previous Ross procedure for aortic valve 
stenosis. Only 2 patients with reoperations had Williams-Beuren syndrome. Both underwent 
surgical repair of supravalvar aortic stenosis (1 native stenosis and 1 re-stenosis after surgical 
repair in childhood). 
At their first clinic visit in the adult clinic 51 patients (45%) had unrepaired or recurrent 
supravalvar aortic stenosis, including 7 patients with a peak systolic gradient ≥ 50 mmHg. Four of 
the 7 patients with significant gradients (≥ 50 mmHg) at first visit to the adult clinic underwent 
cardiac repair soon after presentation, while the other 3 patients with significant supravalvar 
aortic stenosis gradients are still under observation. Patients with cardiac surgery in adulthood 
had higher left ventricular mass at first clinic visit in adulthood compared to those without (117  ± 
35 g/m2 versus 91 ± 31 g/m2, p = 0.019), but left ventricular ejection fractions were not 
significantly different (65 ± 11% versus 63 ± 6%, p = 0.43). Determinants of the need for cardiac 
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surgery in adulthood are shown in Table 4. In contrast to determinants for adverse cardiovascular 
events, neither mitral valve disease at first clinic visit (p=0.739) nor reoperation for supravalvar 
aortic stenosis in childhood (p=1.000) were associated with cardiovascular surgery during follow 
up in adulthood. As for cardiovascular complications, left ventricular mass was a determinant for 
reoperations, but not fractional left ventricular shortening or left ventricular ejection fraction. 
Surgical repair of supravalvar aortic stenosis in childhood was not a significant determinant of 
cardiac operations during follow-up in adulthood (HR 5.2, 95%CI 0.7-40.2, p = 0.12). 
Other Postoperative Complications Related To Prior Surgery Of Supravalvar Stenosis 
There were no adults with pseudoaneurysms or aneurysms at the site of previous patch 
repair. At their first clinic visit in the adult clinic, 3 patients had an enlarged aortic root 
(maximum 4.5cm) and 1 patient had a dilated proximal ascending aorta (4.7cm) after a Ross-
operation. During follow-up, 3 additional patients developed dilatation of the proximal ascending 
aorta (maximum diameter 4.6cm); 2 in the setting of a bicuspid aortic valve. 
Progression of Supravalvar Aortic Stenosis 
Of 51 patients with supravalvar aortic stenosis (native stenosis or re-stenosis) at first 
clinic visit in the adult clinic, 4 underwent surgical repair shortly after presentation. Of the 
remaining 47 patients, serial echocardiograms were available in 75% of the patients (n=35). 
Figure 2 shows the serial supravalvar gradients over time. On average, the supravalvar gradients 
changed little during follow up [median gradient at first clinic visit in adulthood 28 mmHg (IQR 
21-47) versus median gradient at last follow up in the adult clinic 24 mmHg (IQR 16-40), p = 
0.046]. Of those patients without residual supravalvar aortic stenosis at first clinic visit in the 
adult clinic, none had a significant increase in peak supravalvar gradients on serial 
echocardiographic follow-up. As illustrated in Figure 2, three patients (9%) had serial increases in 
the peak supravalvar systolic gradient (increase from 20 to 35 mmHg, 50 to 70 mmHg and from 
70 to 90 mmHg) over a follow-up period of 2.5, 13.7 and 7.0 years. All three patients remained 
asymptomatic and none experienced cardiovascular complications. The patient with a peak 
 11/22 
systolic gradient of 90 mmHg at last clinic visit declined surgical repair. The patient with an 
increase in peak pressure gradient from 50 to 70 mmHg over a follow-up period of 13.7 years had 
serial cardiac magnetic resonance imaging at last follow-up and 12 years earlier with 
morphologically unchanged findings and a minimal supravalvar aortic diameter of 15 mmHg. No 
additional imaging was available in the 2 other patients. 
 
 
Discussion 
Patients with supravalvar aortic stenosis presenting to adult congenital cardiac clinics 
represent a heterogeneous population. Although supravalvar aortic stenosis can be associated with 
Williams-Beuren syndrome, almost half of all adults in our series had either an isolated form of 
supravalvar aortic stenosis or supravalvar aortic stenosis in conjunction with other left ventricular 
outflow tract obstructive lesions. The associated valvular cardiac lesions are common and are 
important determinants of long-term outcomes in the adult. 
Adverse Cardiovascular Events 
Adverse cardiovascular events occurred in more than 1/10 young adults (median age 28 
years) with supravalvar aortic stenosis, primarily due to arrhythmias (both atrial and ventricular) 
and heart failure. Similar to other surgically repaired congenital lesions, multiple operations and 
subsequent scar tissue may act as a source of reentry circuits and increase the propensity toward 
arrhythmias. 
14
 Supravalvar aortic stenosis was not the primary determinant of late complications. 
In contrast to the manifestations reported in the pediatric series, mitral valve disease 
(regurgitation or stenosis) is an important determinant of cardiac complications in the adult.  
Williams-Beuren syndrome is caused by 7q11.23 deletion and although this region contains a 
number of genes, the elastin gene is felt to be the gene responsible for the clinical findings.
1
 The 
involvement of the mitral valve, particularly mitral valve prolapse or regurgitation, in a condition 
affecting elastin fibers is not surprising. Indeed, despite a relatively short follow-up period, 
 12/22 
progressive mitral regurgitation was identified in a number of these patients.
15
 Our findings 
underscore the need to focus on concomitant valvar cardiac lesions, particular mitral valve lesions 
for optimal long-term care of these patients.  Clinical and echocardiographic surveillance in 
adults with supravalvar aortic stenosis, even those without overt valvar heart disease, is 
important.  
In children with supravalvar stenosis, acute coronary syndromes and sudden cardiac 
death are well documented outcomes. 
16
 In our series, one patient had an aborted sudden death 
which occurred in the setting of severe residual supravalvar aortic stenosis, with normal coronary 
arteries. No adults presented with acute coronary syndromes. In children, ostial coronary artery 
lesions are typically caused by abnormal growth of the aortic root. 
2
 While coronary events might 
have been detected in a larger cohort of patients or during a longer follow up period, it may be 
that the case that the mechanism responsible for coronary artery obstruction in children is not 
present in the adult population. Nonetheless, as this population ages, acquired atherosclerotic 
coronary artery disease may become more important. 
17
 Residual supravalvar aortic stenosis may 
accelerate coronary atherosclerosis as in these patients the offset of the coronary arteries is 
proximal to the anatomic narrowing and thus, even in patients without systemic hypertension, 
coronary arteries face an increased systolic pressure. Long-term cohort studies will be needed to 
better define late coronary outcomes in these patients.  
Cardiac Surgery 
Cardiac surgery during adulthood was required in approximately 1/10 young adults 
(median age 23 years) in this study. Cardiac surgeries varied significantly; one third of the adults 
required surgery for severe recurrent or native supravalvar aortic stenosis and the remainder 
required surgery for other indications, including left and right-sided valve disease.  Cardiac 
surgery was more common in patients without Williams-Beuren syndrome, likely because of a 
higher frequency of associated aortic valve lesions in these patients. In our cohort, the presence of 
complete right bundle branch block was also associated with cardiac operations during adulthood. 
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We presume that this finding might be a reflection of more previous cardiac surgery in patients 
with right bundle branch block and although statistically significant it is less clinically 
meaningful. Not surprisingly, a high gradient across the ascending aorta was a strong predictor 
for cardiac surgery. Continued surveillance for concomitant valve disease, in any position, is 
important. 
Progression of Supravalvar Aortic Stenosis 
Progression of supravalvar aortic stenosis may occur in the adult population, but it is less 
common than in children. In most adults, systolic gradients remain stable. This contrasts some 
studies in children with supravalvar aortic stenosis, in whom stenosis was progressive in up to 
80%. 
4
 Differences in the behavior of supravalvar obstruction in children and adults may be 
explained by the different nature of left ventricular outflow tract obstruction in these patients. 
Supravalvar narrowing is typically the consequence of differential growth of the aortic root 
during somatic growth and is not the result of degenerative tissue changes or progressive tissue 
ingrowth or hyperplasia. 
4
 Therefore it seems plausible that lesions are often progressive during 
childhood but remain stable, once growth of the aortic root is completed. 
Limitations 
This study inherits all limitations of a retrospective design. We could not ensure 
standardized clinical and genetic testing for Williams-Beuren syndrome. The diagnosis of this 
syndrome was obtained from available clinic reports and the screening process for Williams-
Beuren syndrome in patients with supravalvar aortic stenosis may differ between sites. 
Information on more contemporary genetic testing was not performed or available.  
There are also limitations with respect to echocardiography. Measurements of left 
ventricular ejection fraction, left ventricular fractional shortening and left ventricular muscle mass 
index were not available in all patients. No established criteria and thresholds exist for the 
definition of supravalvar aortic stenosis and its progression by means of Doppler 
echocardiography. In fact, some groups defined presence and progression as morphologic 
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narrowing at the supravalvar level, without hemodynamic criteria.
8
 Because no specific criteria 
are available, the echocardiographic cut-offs used in this study are therefore arbitrary. 
Furthermore, echocardiographic Doppler-gradients may over- or underestimate the severity of 
supravalvar aortic stenosis depending on many factors including the left ventricular systolic 
function and the nature of stenosis (tubular versus discrete).   
Our study population was relatively young and therefore, with ageing of this population, 
the frequency of complications and the need for operation may increase. Despite the multicenter 
efforts of this study, the number of identified patients with this diagnosis remains small. To better 
define outcomes and risk factors, prospective multicenter registries will be needed to identify 
predictors for long-term outcomes in patients with this rare cardiac condition.  
 
 
Conclusions 
Adults with supravalvar aortic stenosis remain at risk for cardiac complications in adulthood.. 
Adverse cardiovascular events are associated with valve disease, particularly the mitral valve. 
Surgery may be needed in some adults with supravalvar aortic stenosis, but surgical interventions 
are more commonly required for valve lesions and not resection of recurrent supravalvar aortic 
stenosis. 
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Legends 
 
Figure 1: Survival free of cardiovascular complication and reoperation 
Kaplan-Meier plots demonstrating survival free of cardiovascular complications and reoperation 
during follow-up in adults stratified according in those with and without Williams-Beuren 
syndrome (WBS) 
 
 
Figure 2: Serial peak systolic gradients at supravalvar aortic level 
Systolic peak gradients at supravalvar aortic level at last pediatric cardiology visit, first visit in 
the adult clinic and last visit in the adult clinic: Each line represents an individual patient with 
residual stenosis at first clinic visit in the adult clinic. Red lines mark the 3 patients with an 
increase in systolic gradients > 10mmHg during follow-up in adulthood. 
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Table 1A: Clinical baseline characteristics of study patients  
 
Characteristics N=113 
Demographics N (%) 
Males 77 (68) 
Age at first visit in adulthood (years) 20.3 ± 4.3 
Williams-Beuren syndrome 62 (55) 
Cardiac Anatomy  
Diffuse form of supravalvar aortic stenosis 16 (14) 
Involvement of coronary arteries 4 (4) 
Documented renal artery stenosis 8 (7) 
Documented involvement of aortic branches other than renal arteries 4 (4) 
Involvement of other levels of left ventricular outflow tract obstruction 24 (21) 
Shone’s complex 2 (2) 
Surgical history  
Surgical repair of supravalvar aortic stenosis in childhood 76 (67) 
Age at repair (years) 7.5 (IQR 1.7-11.4) 
Additional procedures at the time of repair 30 (27) 
More than one cardiac surgery during childhood 38 (34) 
Reoperation for supravalvar aortic stenosis in childhood 11 (10) 
Reoperation for other cardiac lesions in childhood 19 (17) 
Clinical findings at first visit in adulthood  
Arterial hypertension 29 (26) 
New York Heart Association functional class ≥ 2 9 (8) 
Cardiac medications 36 (33) 
Beta-blockers 12 (11) 
Calcium channel blocker 6 (5) 
Angiotensin-converting enzyme (ACE) inhibitors 17 (15) 
Angiotensin II receptor antagonists 1 (1) 
Diuretics 6 (5) 
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Table 1B: Electrocardiographic and echocardiographic baseline characteristics at first 
clinic visit in adulthood 
 
Characteristics N=113* 
Electrocardiography at first visit in adulthood  
Sinus rhythm at presentation in adulthood 111 (98) 
Complete left bundle branch block 4 (4) 
Complete right bundle branch block 12 (11) 
Echocardiography at first visit in adulthood  
Native or residual supravalvar aortic stenosis (peak gradient ≥ 16 mmHg) 51 (45) 
Peak systolic gradient across supravalvar aortic stenosis 27 (IQR 20-45) 
Supravalvar aortic stenosis with peak gradient ≥ 50 mmHg 7 (6) 
Aortic valve disease  
Bicuspid aortic valve 17 (15) 
Aortic stenosis with peak systolic velocity > 3m/s 11 (10) 
More than mild aortic regurgitation 11 (10) 
Subvalvar aortic stenosis 2 (2) 
Coarctation of the aorta with peak systolic gradient ≥ 20 mmHg 12 (11) 
Mitral valve disease  
 Any mitral valve disease 18 (16) 
Mitral valve prolapse 14 (12) 
Mitral stenosis (mean gradient ≥ 5 mmHg) 3 (3) 
More than mild mitral regurgitation 4 (4) 
Right ventricular outflow tract obstruction  3 (3) 
Left ventricular ejection fraction (%)* 64 ± 7 
Left ventricular fractional shortening (%) 39 ± 8 
Left ventricular muscle mass, indexed to body surface area (g/m
2
) 93 ± 32 
* Left ventricular ejection fraction was reported to be normal in 110 patients (97%), numeric values were 
available in 72 patients (64%). Measurements of left ventricular fractional shortening were available in 
93/113 patients (82%). Measurements of left ventricular muscle mass index were available in 83/113 
patients (73%) 
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Table 2: Cardiovascular outcomes during adulthood in patients with supravalvar aortic 
stenosis 
 N=96 Comments 
Adverse Cardiovascular Events   
   Any adverse cardiovascular event  20 
Median age 28 years  
(range 19-51) 
   Cardiovascular death 2 
Both deaths were secondary to 
heart failure 
   Arrhythmias 8  
Atrial flutter or atrial fibrillation 7 
Two patients had paroxysmal 
atrial flutter / fibrillation in 
combination with sustained 
ventricular tachycardia 
Sustained ventricular tachycardia 3 
One patient had an aborted 
sudden cardiac death 
   New onset heart failure 7  
   Ischemic stroke 1  
   Endocarditis  2 
Two patients had aortic valve 
endocarditis  
Cardiac Surgery   
   Any Cardiac Surgery 12 
Median age 23 years  
(range 19-52) 
   Procedures for supravalvar aortic stenosis    
     Intervention for restenosis after childhood surgery* 3  
     Intervention for newly diagnosed severe 
     supravalvar aortic stenosis 
1  
   Aortic valve procedures   
     Prosthetic aortic valve replacement 2  
     Konno procedure  1  
     Bentall operation 1  
   Combined aortic and mitral valve procedures   
     Aortic valve and mitral valve replacement 1  
   Procedures for right sided heart valves   
     Tricuspid valve repair 1  
     Percutaneous pulmonary valve replacement  1  
   Other procedures   
     Implantation of left ventricular assist device 1  
* Including 1 patient who underwent percutaneous stenting of supravalvar aortic stenosis 
Cardiovascular events and operations are not mutually exclusive 
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Table 3 Determinants of adverse cardiovascular events during adulthood in patients  
with supravalvar aortic stenosis  
 
Hazard 
Ratio 
95% 
Confidence 
Interval 
P Value 
Univariate analysis 
Anatomic variables    
      Diffuse form of supravalvar aortic stenosis 
 
7.9 
 
 2.3 - 27.6 
 
0.001 
Involvement of aortic branches other than renal arteries 3.1 0.9 - 11.5 0.089 
   Clinical variables    
      No diagnosis of Williams-Beuren syndrome 1.7 0.5 -  5.4 0.373 
Reoperation for supravalvar aortic stenosis in childhood 3.9 1.0 - 15.0 0.051 
Multiple cardiac operations in childhood 6.1 1.6 - 22.6 0.007 
NYHA functional class ≥ 2 9.5 2.5 - 35.5 0.001 
Beta-Blocker 4.0 1.0 - 15.7 0.044 
ACE inhibitor 4.2 1.2 - 14.9 0.027 
   Electrocardiographic variables    
Right bundle branch block 7.3 2.0 - 25.8 0.002 
   Echocardiographic variables    
      Any residual supravalvar aortic stenosis at first clinic 
      visit in adulthood 
1.3 0.4 - 4.5 0.643 
      Peak systolic gradient of supravalvar aortic stenosis 
      > 50 mmHg 
1.2 0.2 - 9.7 0.842 
      Any hemodynamically significant mitral valve disease* 7.8 1.6 - 37.4 0.011 
  More than mild mitral regurgitation 7.8 1.0 - 62.8 0.053 
  Mitral stenosis 6.2 0.8 – 49.7 0.086 
Left ventricular fractional shortening 0.872 0.802-0.948 0.001 
Left ventricular ejection fraction 0,956 0.844-1.082 0.48 
Left ventricular muscle mass index 1.028 1.010-1.046 0.002 
*more than mild mitral regurgitation or mitral stenosis with mean diastolic pressure gradient > 5 mmHg
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Table 4. Determinants of cardiac surgery during adulthood in  patients with supravalvar 
aortic stenosis  
 
Hazards 
Ratio 
95% 
Confidence 
Interval 
P Value 
Univariate analysis    
   Anatomic variables    
Diffuse form of supravalvar aortic stenosis 3.5 0.9 - 13.5 0.075 
   Clinical variables    
      No diagnosis of Williams-Beuren syndrome 6.4 1.4 - 29.6 0.017 
      Reoperation for supravalvar aortic stenosis in  
      childhood 
1.0 0.1-7.7 1.0 
Multiple cardiac operations in childhood 3.8 1.1 - 12.5 0.030 
NYHA functional class ≥ 2 6.3 1.6 - 25.7 0.010 
   ECG variables    
Right bundle branch block 5.1 1.5 - 16.9 0.008 
   Echocardiographic variables    
Peak systolic gradient of supravalvar aortic stenosis 
> 50 mmHg 
5.2 1.4 - 19.8 0.015 
More than mild aortic regurgitation 3.2 0.9 - 11.0 0.070 
Any hemodynamically significant aortic valve disease* 2.8 0.8 - 9.1 0.097 
Any significant mitral valve disease at first visit in 
adulthood 
0.7 0.1-5.6 0.739 
Left ventricular fractional shortening 0.956 0.881-1.036 0.269 
Left ventricular ejection fraction 1.068 0.971-1.175 0.174 
Left ventricular muscle mass index 1.019 1.003-1.035 0.018 
* Aortic stenosis with peak systolic velocity > 3m/s and/or more than mild aortic regurgitation 
 
